All In MedTech

Device Trial Radar · NCT04472091

Genicular Artery Embolization (GAE) for Osteoarthritic Knee Pain

Genicular Artery Embolization for the Treatment of Moderate to Severe Osteoarthritic Knee Pain

Last checked: Nov 19, 2026Latest source record: Feb 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Jan 15, 2025

Primary completion

Nov 1, 2026

Study completion Nov 1, 2026

Sponsor

Lead sponsor
Andrew PicelAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 15, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this investigation is to evaluate the safety of the geniculate artery embolization (GAE) procedure with HydroPearl® Microspheres in 30 patients with knee pain caused by osteoarthritis with 24 months follow-up. The GAE procedure is an arterial embolization procedure that blocks abnormal blood vessels caused be knee arthritis in order to evaluate the effect on knee pain.

Conditions

  • Knee Osteoarthritis
  • Knee Pain Chronic
  • Knee Pain Swelling
  • Knee Arthritis
  • Arterial Occlusion

Interventions

  • Genicular artery embolization (GAE)Device

    Participants will undergo GAE with HydroPearl® Microspheres (polyethylene glycol microspheres, Terumo Medical, Somerset NJ).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of patients with treatment related adverse eventsTime frame: 1 month post GAE
  2. Number of patients with treatment related adverse eventsTime frame: 6 months post GAE
  3. Number of patients with treatment related adverse eventsTime frame: 12 months post GAE

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Stanford University

    Palo Alto, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.